THC Global Group Limited (ASX:THC)(OTCMKTS:HDRPF) is pleased to advise that the Company's wholly owned subsidiary, THC Pharma Pty Ltd, has been granted a Manufacture Licence from the Australian Office of Drug Control for its Southport Manufacturing Facility.
Anatara Lifesciences (ASX:ANR) provides an update on the strategic evaluation of Detach(R), its non-antibiotic animal health asset which aids in the control of diarrhoeal disease in piglets with potential application in other livestock animals, aquaculture and companion animals.
Anatara Lifesciences (ASX:ANR) releases the presentation which Chief Executive Officer, Mr Steven Lydeamore, will present to investors in Perth this week and to the Gold Coast Investment Showcase later this month.
Anatara Lifesciences (ASX:ANR) announces that Zoetis Inc. has given notice of termination of the exclusive worldwide license of Detach(R) for livestock and horses. Zoetis made a portfolio decision not to continue with the pursuit of this asset.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) provides the MMJ Investment Portfolio Report as at 31 May 2019. This report includes details of MMJ's net tangible asset per share as at 31 May 2019 pursuant to Listing Rule 4.12 as a listed investment company.
THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) is pleased to advise that THC Global, through its wholly owned subsidiary Canndeo Limited, has been granted a Manufacture Licence for the production of extracts and tinctures of cannabis and cannabis resin from the Australian Office of Drug Control.
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to announce an on-market buy-back of up to 10m MMJ ordinary shares over the next 12 months ('buy-back') as part of its active approach to capital management.
